Skip to main content

Advertisement

Table 3 Summary of the visits

From: Decrease of a specific biomarker of collagen degradation in osteoarthritis, Coll2-1, by treatment with highly bioavailable curcumin during an exploratory clinical trial

  Patients Blood collection Adverse events Concomitant treatment Drop off
V1 22 22 - - -
V2 22   9.1% 50.0%  
(7 days)
V3 22 22 14.3% 45.4% 1
(14 days)
V4 21   14.3% 35.0% 1
(28 days)
V5 (84 days) 20 20 25% 55.6%  
  1. V1: first visit, at the time of selection; V2: visit after 7 days of treatment ; V3: visit after 14 days of treatment; V4: visit after 28 days of treatment; V5: visit after 84 days of treatment.
  2. Knee OA patients with night pain and effusion were asked to take 2x3 caps of an enriched curcumin extract twice a day for 3 months from V1. They were visited after 7, 14, 28 and 84 days of treatment.